DR. INFO vs OpenEvidence (2026): Which Medical AI Fits European Practice?

DR. INFO and OpenEvidence, side by side

How DR. INFO compares with OpenEvidence

Frequently asked questions

Is OpenEvidence available in Europe or the UK in 2026?

No. OpenEvidence withdrew on 28 April 2026, and access from European IP addresses is now blocked ^[3]. DR. INFO is available across Europe and is CE marked under EU MDR 2017/745.

What is the best OpenEvidence alternative for European physicians?

DR. INFO is built for this case: European origin, CE marked under EU MDR, GDPR compliant EU hosting, answers in any language, and cited answers from peer reviewed literature, clinical guidelines and FDA and EMA sources. Independent comparisons of the two tools reach the same conclusion for European practice ^[4]. It also avoids the access problem non-US clinicians hit with OpenEvidence, which verifies through the US National Provider Identifier system that physicians outside the United States do not hold ^[5].

How does DR. INFO differ from other European alternatives?

Several tools became available to European clinicians after OpenEvidence withdrew. The distinctions worth checking on any of them are the same: whether it is a CE marked medical device under EU MDR rather than a general information service, whether data is hosted in the EU, whether every claim carries a citation you can open to the exact page, and whether it answers in the language you work in. DR. INFO is CE marked under MDR 2017/745, EU hosted under GDPR, cites to page level with paragraph level document interrogation, and answers in almost any language.

Does DR. INFO cover German and other national guidelines?

Yes. Alongside international and European society guidelines such as ESC, ESMO, NICE, KDIGO and WHO, DR. INFO retrieves national guidance including German AWMF and DGVS sources, and answers in German. National guidelines are personalised to your country setting, while international and wider European guidelines are returned regardless of country, so you get both the local and the broader picture. Coverage is broad but not exhaustive for any single body, and the source document is linked on every answer.

How does DR. INFO compare with OpenEvidence on benchmarks?

On HealthBench Hard, a benchmark of difficult clinical conversations built by physicians, DR. INFO scored 0.72 against 0.49 for OpenEvidence in the same 100 example run ^[6]. HealthBench was published by OpenAI ^[7]. The evaluation was run by our team with methods published in full, so read it alongside the pilot study of how physicians rated DR. INFO in practice ^[8].

Is DR. INFO free for physicians and medical students?

Yes, there is a free tier for physicians and medical students. Details are on the pricing page.

Is DR. INFO a certified medical device?

Yes. DR. INFO is CE marked under EU MDR 2017/745 ^[9], developed and operated by Synduct GmbH in Munich.

Can DR. INFO cite the wrong paper?

Any AI system can err, which is why every answer links to its sources. Citations are inline with direct links, so you can check a claim against the original reference in seconds. DR. INFO also refuses to answer when the evidence is insufficient rather than guessing.

Does DR. INFO read full papers or only abstracts?

DR. INFO retrieves from full text where it is available, including clinical guideline documents, which it can interrogate at the paragraph level rather than summarising an abstract. This matters because an abstract often omits the population, the comparator or the limitation that decides whether a finding applies to your patient.

How does DR. INFO avoid journal prestige bias?

Retrieval is driven by clinical relevance to the question and by the standing of the evidence itself, such as guideline status and study design, rather than by journal brand alone. Because every claim carries a linked citation, you can see which source an answer rests on and judge it yourself instead of trusting a ranking you cannot inspect.

What languages does DR. INFO support?

You can ask in almost any language, European or beyond, and the answer follows the language of your question. The product itself, its interface and pages, is offered in four languages: English, German, Portuguese and Dutch.

References

1. 1.Breaking: OpenEvidence app access terminated in the UK and EU. Telehealth and Telecare Aware. 28 April 2026.
2. 2.OpenEvidence exits Europe, highlighting divide in health AI rules. Telehealth.org. 2026.
3. 3.The US-based medical search engine OpenEvidence is down in Europe: a commentary on regulatory complexities. Intelligence-Based Medicine. 2026.
4. 4.DR. INFO vs OpenEvidence: comparison for UK and EU clinicians. iatroX. 3 May 2026.
5. 5.OpenEvidence outside the US: access, verification, and practical alternatives. iatroX. 2026.
6. 6.Ravichandran S, Kumar S, Corga Da Silva R, Romano M, et al. OpenAI’s HealthBench in Action: Evaluating an LLM-Based Medical Assistant on Realistic Clinical Queries. arXiv:2509.02594. 2026.
7. 7.Arora RK, Wei J, Soskin Hicks R, et al. HealthBench: Evaluating Large Language Models Toward Improved Human Health. OpenAI. 2025.
8. 8.Corga Da Silva R, Romano M, Mendes T, et al. DR. INFO at the Point of Care: A Prospective Pilot Study of Physician-Perceived Value of an Agentic Artificial Intelligence Clinical Assistant. Cureus. 2026.
9. 9.Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (EU MDR). Official Journal of the European Union. 2017.